Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. May 7, 2013; 19(17): 2709-2713
Published online May 7, 2013. doi: 10.3748/wjg.v19.i17.2709
Table 1 The 5’ amplification primer mix included the following primers
5'-CCACAGCACGTTTCTTGGAGTACTCTA-3'
5'-CCAGTTTCTTGTGGCAGCTTAAGTT-3'
5'-TCGTTCCTGTGGCAGGGTAAGTATA-3'
5'-AGCCGTTTCTTGAAGCAGGATAAGTT-3'
5'-CCAAGCACGTTTCTTGGAGGAGG-3'
5'-TCGTTCCTGTGGCAGCCTAAGA-3'
5'-AGCCGTTTCTTGGAGCAGGTTAAAC-3'
Table 2 Clinical characteristics of the study subjects n (%)
CharacteristicsUC patientsControlsP value
Total number (n)102310
Han531610.998
Uyghur491490.998
Gender, M/F47/55137/1730.740
Age of onset1, yr48.07 ± 15.8347.37 ± 14.490.801
Extensive colitis (Han)20 (38)
Extensive colitis (Uyghur)30 (61)
Distal colitis (Han)33 (62)
Mild and intermediate47 (89)
Severe6 (11)
Distal colitis (Uyghur)19 (39)
Mild and intermediate40 (82)
Severe9 (18)
Table 3 Genotypic association between DRB1* variants and ulcerative colitis in the Han and Uyghur population
Han UC (n = 53)Controls (n = 161)χ2P valueUyghur UC (n = 49)Controls (n = 149)χ2P value
n (%)Genotype frequenciesn (%)Genotype frequenciesn (%)Genotype frequenciesn (%)Genotype frequencies
HLA-DRB1**0100001 (2.04)0.010003.0560.247
HLA-DRB1**036 (11.32)0.05836 (22.36)0.1193.0810.1108 (16.33)0.08530 (20.13)0.1060.3450.678
HLA-DRB1**044 (7.55)0.0394 (2.49)0.0132.8400.1065 (10.21)0.0524 (2.69)0.0144.8050.043
HLA-DRB1**083 (5.66)0.0299 (5.59)0.0280.0001.0000015 (10.07)0.0525.3370.024
HLA-DRB1**1111 (20.76)0.11018 (11.18)0.0583.1200.1038 (16.33)0.08539 (26.18)0.1411.9750.180
HLA-DRB1**1222 (41.51)0.23578 (48.45)0.2820.7710.42913 (26.53)0.14351 (34.23)0.1890.9990.380
HLA-DRB1**131 (1.89)0.0099 (5.59)0.0281.2280.4577 (14.29)0.0746 (4.03)0.0226.3260.019
HLA-DRB1**146 (11.32)0.0587 (4.35)0.0233.3980.0937 (14.29)0.0744 (2.69)0.0149.4580.006